Guanqun Xie

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Radiation Therapy

Rheumatoid Arthritis Patients

Disease Activity

Top Venues

Drug design, development and therapy

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Yunxia Liu, Yun Ye, Guanqun Xie, Yefeng Xu, Miao Cheng, Chunling Li, Mengqi Qu, Feiye Zhu
Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation. Drug design, development and therapy 17 (2023)
Yunxia Liu, Yun Ye, Guanqun Xie, Yefeng Xu, Miao Cheng, Chunling Li, Mengqi Qu, Feiye Zhu
Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation. Drug design, development and therapy 17 (2023)
Yunxia Liu, Yun Ye, Guanqun Xie, Yefeng Xu, Miao Cheng, Chunling Li, Mengqi Qu, Feiye Zhu
Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation. Drug design, development and therapy 17 (2023)
Shan Wu, Lina Ji, Xuemin Fan, Sijia Fang, Jie Bao, Xiao Yuan, Yongsheng Fan, Guanqun Xie
Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF- β 1/Smad2/3 Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Lina Ji, Shenglong Wang, Shan Wu, Jie Bao, Guanqun Xie, Yan Zhang, Liping Xu, Na Lin, Jian Wang, Yongsheng Fan, Danqing Fu, Qiaoding Dai
Paeoniflorin Inhibits LPS-Induced Activation of Splenic CD4 + T Lymphocytes and Relieves Pathological Symptoms in MRL/lpr Mice by Suppressing IRAK1 Signaling. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Feiye Zhu, Yanli Xu, Jieli Pan, Meiya Li, Fangming Chen, Guanqun Xie
Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)